ATE288762T1 - Kardiopflegische lösung - Google Patents

Kardiopflegische lösung

Info

Publication number
ATE288762T1
ATE288762T1 AT01958751T AT01958751T ATE288762T1 AT E288762 T1 ATE288762 T1 AT E288762T1 AT 01958751 T AT01958751 T AT 01958751T AT 01958751 T AT01958751 T AT 01958751T AT E288762 T1 ATE288762 T1 AT E288762T1
Authority
AT
Austria
Prior art keywords
cardio
care solution
potassium
prevention
connection
Prior art date
Application number
AT01958751T
Other languages
English (en)
Inventor
Stig Steen
Original Assignee
Jolife Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolife Ab filed Critical Jolife Ab
Application granted granted Critical
Publication of ATE288762T1 publication Critical patent/ATE288762T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Manufacturing Of Printed Circuit Boards (AREA)
AT01958751T 2000-08-07 2001-08-07 Kardiopflegische lösung ATE288762T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0002832A SE0002832D0 (sv) 2000-08-07 2000-08-07 Cardioplegic solution
US23081200P 2000-09-07 2000-09-07
PCT/SE2001/001719 WO2002011741A1 (en) 2000-08-07 2001-08-07 Cardioplegic solution

Publications (1)

Publication Number Publication Date
ATE288762T1 true ATE288762T1 (de) 2005-02-15

Family

ID=26655198

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01958751T ATE288762T1 (de) 2000-08-07 2001-08-07 Kardiopflegische lösung

Country Status (8)

Country Link
US (1) US7270833B2 (de)
EP (1) EP1307209B1 (de)
AT (1) ATE288762T1 (de)
AU (1) AU2001280372A1 (de)
DE (1) DE60108880T2 (de)
ES (1) ES2233669T3 (de)
SE (1) SE0002832D0 (de)
WO (1) WO2002011741A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2543249B1 (de) 2007-02-17 2018-05-23 President and Fellows of Harvard College Zusammensetzungen und verfahren zur Gewebekonservierung
CA2715634A1 (en) * 2008-02-15 2009-08-27 President And Fellows Of Harvard College Blood substitute solution
US20110059177A1 (en) * 2008-02-15 2011-03-10 Hemant Thatte Cardioplegia Solution for Cardiac Surgery
US9206380B2 (en) 2013-03-14 2015-12-08 Ecolab Usa Inc. Method of generating carbonate in situ in a use solution and of buffered alkaline cleaning under an enriched CO2 atmosphere
WO2015168540A1 (en) * 2014-05-01 2015-11-05 Berry Catherine E A modified single dose, microplegic approach to cardioplegia for the adult heart
TR201901995T4 (tr) * 2014-07-11 2019-03-21 Llc Cardiosystempharma Llc Csp Evrensel kardiyoplejik çözelti (varyantlar).
US10091986B2 (en) 2016-05-09 2018-10-09 Xor-Labs Toronto Inc. Organ perfusion device and method
CN113975377B (zh) * 2020-07-27 2023-11-10 成都青山利康药业股份有限公司 一种心脏停搏液

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1176651B (de) * 1960-07-05 1964-08-27 Roussel Uclaf Verfahren zur Herstellung von 20, 20-bis-Hydroxymethyl-3-keto-1, 4-pregnadienen bzw. Estern derselben
RU2036646C1 (ru) * 1991-08-02 1995-06-09 Новосибирский научно-исследовательский институт патологии кровообращения Способ защиты миокарда при операциях на сердце в условиях бесперфузионной гипотермии
US5552267A (en) * 1992-04-03 1996-09-03 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
US6449507B1 (en) * 1996-04-30 2002-09-10 Medtronic, Inc. Method and system for nerve stimulation prior to and during a medical procedure
RU2144362C1 (ru) * 1997-08-26 2000-01-20 Научно-исследовательский институт патологии кровообращения Способ профилактики нарушений ритма сердца при кардиохирургических операциях

Also Published As

Publication number Publication date
DE60108880T2 (de) 2005-06-23
EP1307209A1 (de) 2003-05-07
DE60108880D1 (de) 2005-03-17
US20040018245A1 (en) 2004-01-29
SE0002832D0 (sv) 2000-08-07
US7270833B2 (en) 2007-09-18
AU2001280372A1 (en) 2002-02-18
WO2002011741A1 (en) 2002-02-14
EP1307209B1 (de) 2005-02-09
ES2233669T3 (es) 2005-06-16

Similar Documents

Publication Publication Date Title
ATE556742T1 (de) Seitenumkehrung in einem system zur regelung des herzrhythmus
BR0108452A (pt) Inibidores da oxidação parcial de ácido graxo no tratamento de insuficiência cardìaca congestiva
ES537769A0 (es) Protesis cardiaca total que incluye dos bombas desacopladas asociadas en una unidad funcional indisociable
ATE161835T1 (de) Benzoylbenzofuranderivate zur behandlung von herzarrhythmia
WO2003020202A3 (en) Method for reducing hypertension and heart failure
IT1170235B (it) Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare
AU4722785A (en) Initiating reperfusion treatment when heart attack symptoms are present
BR9911093A (pt) Dispositivo estimulador e métodos para melhorar o retorno de sangue venoso durante ressuscitação cardiopulmonar.
WO2004082538A3 (en) Body tissue remodeling apparatus
NO20033304D0 (no) Essensielle N-3 fettsyrer i kardialinsuffisiens- og hjertesviktterapi
BR9915314A (pt) Aparelho para auxiliar um coração bombear sangue, método para criá-lo e seu uso
PT1318856E (pt) Cardioversor-desfibrilhador implantável totalmente subcutâneo e estimulador cardíaco opcional
PT986348E (pt) Protese valvular cardiaca em tecido natural
DE69942062D1 (de) Kardioverter zur kardiovertierung einer vorhoftachykardie während fortgesetzter stimulierung des atriums
SE7710575L (sv) Hjertstimulator
SE9702860D0 (sv) New use
IE791235L (en) Acyl-derivatives of carnitine.
ATE288762T1 (de) Kardiopflegische lösung
WO2001058518A8 (en) Cardiac control using paired pacing
DE60138189D1 (de) Eine neue verwendung von deferiprone
NO20031414L (no) Ny oksabispidinforbindelse som er nyttig i behandlingen av hjertearrytmier
DE69929192D1 (de) Herzstimulator mit bestimmung des stimulationsschwellwertes
DE60203318D1 (de) Vorrichtung zur verringerung der wahrscheinlichkeit von vorhofflimmern
DE3686472D1 (de) Cardiotonische phenyloxazolone.
WO2003049683A3 (en) Use of parapox b2l protein to treat cancer and modify immune responses

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties